The Role of Catecholamines in Pathophysiological Liver Processes
- PMID: 35326472
- PMCID: PMC8947265
- DOI: 10.3390/cells11061021
The Role of Catecholamines in Pathophysiological Liver Processes
Abstract
Over the last few years, the number of research publications about the role of catecholamines (epinephrine, norepinephrine, and dopamine) in the development of liver diseases such as liver fibrosis, fatty liver diseases, or liver cancers is constantly increasing. However, the mechanisms involved in these effects are not well understood. In this review, we first recapitulate the way the liver is in contact with catecholamines and consider liver implications in their metabolism. A focus on the expression of the adrenergic and dopaminergic receptors by the liver cells is also discussed. Involvement of catecholamines in physiological (glucose metabolism, lipids metabolism, and liver regeneration) and pathophysiological (impact on drug-metabolizing enzymes expression, liver dysfunction during sepsis, fibrosis development, or liver fatty diseases and liver cancers) processes are then discussed. This review highlights the importance of understanding the mechanisms through which catecholamines influence liver functions in order to draw benefit from the adrenergic and dopaminergic antagonists currently marketed. Indeed, as these molecules are well-known drugs, their use as therapies or adjuvant treatments in several liver diseases could be facilitated.
Keywords: dopamine; epinephrine; hepatic cells; norepinephrine; sympathetic innervation.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8947265/bin/cells-11-01021-g005.gif)
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8947265/bin/cells-11-01021-g001.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8947265/bin/cells-11-01021-g002.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8947265/bin/cells-11-01021-g003.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8947265/bin/cells-11-01021-g004.gif)
![Figure 6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8947265/bin/cells-11-01021-g006.gif)
Similar articles
-
Catecholamines: physiological immunomodulators during health and illness.Curr Med Chem. 2006;13(17):1979-89. doi: 10.2174/092986706777584997. Curr Med Chem. 2006. PMID: 16842192 Review.
-
[ADRENERGIC MECHANISMS].Arch Ital Sci Farmacol. 1963 Jul;13:252-3. Arch Ital Sci Farmacol. 1963. PMID: 14191845 Italian. No abstract available.
-
UPTAKE OF L- AND D-ISOMERS OF CATECHOLAMINES IN ADRENERGIC NERVE GRANULES.Acta Physiol Scand. 1964 Mar;60:217-22. doi: 10.1111/j.1748-1716.1964.tb02884.x. Acta Physiol Scand. 1964. PMID: 14131836 No abstract available.
-
UPTAKE OF RADIOACTIVELY LABELED DL-CATECHOLAMINES IN ISOLATED ADRENERGIC NERVE GRANULES WITH AND WITHOUT RESERPINE.Life Sci (1962). 1963 Nov;11:878-85. doi: 10.1016/0024-3205(63)90103-6. Life Sci (1962). 1963. PMID: 14078143 No abstract available.
-
Mechanisms involved in alpha-adrenergic phenomena: role of calcium ions in actions of catecholamines in liver and other tissues.Am J Physiol. 1980 Jan;238(1):E3-12. doi: 10.1152/ajpendo.1980.238.1.E3. Am J Physiol. 1980. PMID: 6243874 Review.
Cited by
-
The structure of the TH/INS locus and the parental allele expressed are not conserved between mammals.Heredity (Edinb). 2024 Jul;133(1):21-32. doi: 10.1038/s41437-024-00689-y. Epub 2024 Jun 4. Heredity (Edinb). 2024. PMID: 38834866 Free PMC article.
-
Adipocyte HSL is required for maintaining circulating vitamin A and RBP4 levels during fasting.EMBO Rep. 2024 May 20. doi: 10.1038/s44319-024-00158-x. Online ahead of print. EMBO Rep. 2024. PMID: 38769419
-
Treatment with β-Adrenoceptor Agonist Isoproterenol Reduces Non-parenchymal Cell Responses in LPS/D-GalN-Induced Liver Injury.Inflammation. 2024 Apr;47(2):733-752. doi: 10.1007/s10753-023-01941-z. Epub 2023 Dec 21. Inflammation. 2024. PMID: 38129360 Free PMC article.
-
GPCRs and fibroblast heterogeneity in fibroblast-associated diseases.FASEB J. 2023 Aug;37(8):e23101. doi: 10.1096/fj.202301091. FASEB J. 2023. PMID: 37486603 Review.
-
Cracking Brain Diseases from Gut Microbes-Mediated Metabolites for Precise Treatment.Int J Biol Sci. 2023 Jun 4;19(10):2974-2998. doi: 10.7150/ijbs.85259. eCollection 2023. Int J Biol Sci. 2023. PMID: 37416776 Free PMC article. Review.
References
-
- Adori C., Daraio T., Kuiper R., Barde S., Horvathova L., Yoshitake T., Ihnatko R., Valladolid-Acebes I., Vercruysse P., Wellendorf A.M., et al. Disorganization and Degeneration of Liver Sympathetic Innervations in Nonalcoholic Fatty Liver Disease Revealed by 3D Imaging. Sci. Adv. 2021;7:eabg5733. doi: 10.1126/sciadv.abg5733. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical